# Use of a Novel SUBCUTaneous Preparation of Furosemide to Facilitate Early Supported Discharge of Patients With Heart Failure

Study · id `cardio:ct-nct05419115` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05419115](<https://clinicaltrials.gov/study/NCT05419115>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05419115

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 172 participants.

## Technical summary

Registry record NCT05419115. Randomized; no masking; primary purpose treatment. Start 2022-11-17 (actual); primary completion 2026-03-01 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 172 participants (enrolled count; ClinicalTrials.gov record NCT05419115, source copy `cardio:ctgov-nct05419115-2026-03-30`, retrieved 2026-10-26)
- Started: 2022-11-17 (actual) (ClinicalTrials.gov record NCT05419115, source copy `cardio:ctgov-nct05419115-2026-03-30`, retrieved 2026-10-26)
- Primary completion: 2026-03-01 (actual) (ClinicalTrials.gov record NCT05419115, source copy `cardio:ctgov-nct05419115-2026-03-30`, retrieved 2026-10-26)
- Completion: 2026-03-01 (actual) (ClinicalTrials.gov record NCT05419115, source copy `cardio:ctgov-nct05419115-2026-03-30`, retrieved 2026-10-26)
- Countries: United Kingdom (ClinicalTrials.gov record NCT05419115, source copy `cardio:ctgov-nct05419115-2026-03-30`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05419115-2026-03-30`, retrieved 2026-10-26)

## The registry's words

- Brief title: Use of a Novel SUBCUTaneous Preparation of Furosemide to Facilitate Early Supported Discharge of Patients With Heart Failure
- Acronym: SUBCUT-HF II
- Condition: Heart Failure
- Intervention (Drug): SQIN-Furosemide
- Intervention (Device): SQIN-Infusor
- Lead sponsor: NHS Greater Glasgow and Clyde
- Lead sponsor class: OTHER
- Collaborator: University of Glasgow
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: NHS Greater Glasgow and Clyde (`cardio:org-nhs-greater-glasgow-and-clyde`)
- Registry lists this organization as a collaborator: University of Glasgow (`cardio:org-university-of-glasgow`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Early Discharge Strategy Including Subcutaneous Furosemide in Hospitalized Heart Failure (`cardio:pubmed-42872757`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 9f350a834fdd5aff405d164070cd7740b3d3759149a006e310235b033781e3d6
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
